NCT05157958View on ClinicalTrials.gov

Study to Evaluate Safety and Efficacy of ALLO-ASC-SHEET in Subjects With Dystrophic Epidermolysis Bullosa

PHASE2RecruitingINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

May 1, 2023

Primary Completion Date

October 1, 2025

Study Completion Date

April 28, 2026

Conditions
Dystrophic Epidermolysis Bullosa
Interventions
BIOLOGICAL

ALLO-ASC-SHEET

Weekly administration

OTHER

Vehicle Control

Weekly administration

Trial Locations (1)

33125

RECRUITING

University of Miami Dermatology Clinical Trials Unit, Miami

All Listed Sponsors
lead

Anterogen Co., Ltd.

INDUSTRY